ECM
JAZZ icon

Evergreen Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Evergreen Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$520K Sell
2,160
-431
-17% -$94.4K 0.01% 876
2026
Q1 		$490K Buy
2,591
+33
+1% +$5.77K 0.01% 802
2025
Q4 		$435K Buy
2,558
+384
+18% +$58.9K 0.01% 832
2025
Q3 		$287K Buy
+2,174
New +$261K 0.01% 1009
2025
Q2 		– Sell
-2,886
Closed -$358K – 1192
2025
Q1 		$358K Sell
2,886
-1,211
-30% -$158K 0.01% 657
2024
Q4 		$505K Buy
4,097
+273
+7% +$32.2K 0.02% 502
2024
Q3 		$426K Buy
3,824
+981
+35% +$108K 0.01% 572
2024
Q2 		$303K Sell
2,843
-14,815
-84% -$1.63M 0.01% 661
2024
Q1 		$2.13M Buy
17,658
+372
+2% +$45.6K 0.08% 222
2023
Q4 		$2.13M Sell
17,286
-1,164
-6% -$145K 0.09% 224
2023
Q3 		$2.39M Buy
18,450
+491
+3% +$65.4K 0.1% 203
2023
Q2 		$2.23M Buy
17,959
+320
+2% +$43.1K 0.09% 205
2023
Q1 		$2.58M Sell
17,639
-213
-1% -$31.5K 0.12% 189
2022
Q4 		$2.84M Sell
17,852
-423
-2% -$62K 0.13% 181
2022
Q3 		$2.44M Sell
18,275
-262
-1% -$39.8K 0.13% 190
2022
Q2 		$2.89M Sell
18,537
-877
-5% -$135K 0.15% 170
2022
Q1 		$3.02M Sell
19,414
-143
-0.7% -$20.8K 0.12% 195
2021
Q4 		$2.49M Buy
19,557
+2,164
+12% +$284K 0.1% 205
2021
Q3 		$2.27M Buy
+17,393
New +$2.63M 0.1% 200

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Evergreen Capital Management's JAZZ Position: Q2 2026 in Review

Evergreen Capital Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 17% in Q2 2026, selling an estimated $94.4K and leaving 2,160 shares worth $520K. The position accounts for 0.01% of the portfolio, ranked #876.

Evergreen Capital Management first reported a position in JAZZ in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.02M in Q1 2022. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Evergreen Capital Management held 2,160 shares of Jazz Pharmaceuticals worth $520K as of Q2 2026.
  • Evergreen Capital Management sold 431 Jazz Pharmaceuticals shares in Q2 2026, an estimated $94.4K.
  • Jazz Pharmaceuticals made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #876 holding.
  • Evergreen Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Evergreen Capital Management's Jazz Pharmaceuticals position peaked at $3.02M in Q1 2022.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.